Use ESG signals to inform the overall risk posture of a supplier and the intensity of oversight. This does not require turning GCP audits into ESG audits. It means including ESG in risk-based thinking ...

A look at how efficiency, access, platformization, AI, non-traditional players, and regulatory recovery are expected to reshape clinical operations in 2026. As sponsors, CROs, regulators, and ...

Dear reader, imagine there is a new medicine that could change the lives of thousands of patients in Saudi Arabia, but it remains locked inside reports and scientific ...

Services Market OverviewThe global contract research organization services market is poised to register steady growth at an estimated rate of around 9% over the next five years, reflecting the ...

Clinical trial delays impact outcomes. Learn why CROs need a supply chain partner they can trust to reduce delays and help ...

SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- On January 9th, GENEIII reaffirmed its global leadership in ergothioneine production and scientific validation at the "Research Without Borders • Tracing the ...

Opportunities in the market include the rising demand due to increased clinical trials & biosimilar developments, especially in oncology and immunology. Advanced cold chain logistics and AI-driven ...

Early protocol design decisions carry significant operational consequences for clinical supply strategy and randomization and trial supply management (RTSM) performance. Many issues that emerge ...

Over recent decades, advances in cancer treatment have yielded substantial improvements in patient outcomes, driving up survival, and even rendering some cancers curable. These advances have been ...

In A Nutshell Personalized AI “health agents,” virtual drug trials, and automated compliance tools could quietly speed up ...

Listing expected to expand market access and secondary liquidity for Enlivex’s primary digital treasury asset Nes-Ziona, Israel, Jan. 26, 2026 ...